{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,24]],"date-time":"2026-06-24T14:34:24Z","timestamp":1782311664048,"version":"3.54.5"},"reference-count":35,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,2,7]],"date-time":"2026-02-07T00:00:00Z","timestamp":1770422400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,2,19]],"date-time":"2026-02-19T00:00:00Z","timestamp":1771459200000},"content-version":"vor","delay-in-days":12,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"Tianjin Health Research Project","award":["TJWJ2023MS019"],"award-info":[{"award-number":["TJWJ2023MS019"]}]},{"name":"Tianjin Health Research Project","award":["TJWJ2023XK011"],"award-info":[{"award-number":["TJWJ2023XK011"]}]},{"name":"Exceptional Young Talents Fostering Foundation 2021 of the Tianjin Fourth Central Hospital","award":["tjdszxyy20210004"],"award-info":[{"award-number":["tjdszxyy20210004"]}]},{"name":"Tianjin Science and Technology Program Project","award":["24KPHDRC00330"],"award-info":[{"award-number":["24KPHDRC00330"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Endocr Disord"],"DOI":"10.1186\/s12902-026-02188-z","type":"journal-article","created":{"date-parts":[[2026,2,7]],"date-time":"2026-02-07T05:03:56Z","timestamp":1770440636000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Exploration and clinical analysis of the correlation between the triglyceride\u2013glucose index and hyperuricemia in patients with type 2 diabetes: a real-world, retrospective, cross-sectional study with subsequent cohort analysis"],"prefix":"10.1186","volume":"26","author":[{"given":"Dachuan","family":"Xia","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chao","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaoqiang","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiao","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhida","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhaohu","family":"Hao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hailin","family":"Shao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,2,7]]},"reference":[{"issue":"2","key":"2188_CR1","doi-asserted-by":"publisher","first-page":"104","DOI":"10.2174\/1570161117666190405165911","volume":"18","author":"D Lovic","year":"2020","unstructured":"Lovic D, Piperidou A, Zografou I, et al. The growing epidemic of diabetes mellitus. Curr Vasc Pharmacol. 2020;18(2):104\u20139.","journal-title":"Curr Vasc Pharmacol"},{"issue":"17","key":"2188_CR2","doi-asserted-by":"publisher","first-page":"6275","DOI":"10.3390\/ijms21176275","volume":"21","author":"U Galicia-Garcia","year":"2020","unstructured":"Galicia-Garcia U, Benito-Vicente A, Jebari S, et al. Pathophysiology of type 2 diabetes mellitus. Int J Mol Sci. 2020;21(17):6275.","journal-title":"Int J Mol Sci"},{"key":"2188_CR3","doi-asserted-by":"publisher","first-page":"109785","DOI":"10.1016\/j.diabres.2022.109785","volume":"185","author":"H Wu","year":"2022","unstructured":"Wu H, Patterson CC, Zhang X, et al. Worldwide estimates of incidence of type 2 diabetes in children and adolescents in 2021. Diabetes Res Clin Pract. 2022;185:109785.","journal-title":"Diabetes Res Clin Pract"},{"key":"2188_CR4","doi-asserted-by":"publisher","first-page":"108615","DOI":"10.1016\/j.pharmthera.2024.108615","volume":"256","author":"S Wen","year":"2024","unstructured":"Wen S, Arakawa H, Tamai I. Uric acid in health and disease: from physiological functions to pathogenic mechanisms. Pharmacol Ther. 2024;256:108615.","journal-title":"Pharmacol Ther"},{"issue":"6","key":"2188_CR5","doi-asserted-by":"publisher","first-page":"103043","DOI":"10.1016\/j.dsx.2024.103043","volume":"18","author":"R Chen","year":"2024","unstructured":"Chen R, Nie S, Zhou S, et al. Association between urate-lowering therapy initiation and all-cause mortality in patients with type 2 diabetes and asymptomatic hyperuricemia. Diabetes Metab Syndr. 2024;18(6):103043.","journal-title":"Diabetes Metab Syndr"},{"key":"2188_CR6","unstructured":"Freeman AM, Acevedo LA, Pennings N, Insulin R. 2023 Aug 17. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2024 Jan\u2013. PMID: 29939616."},{"issue":"5","key":"2188_CR7","doi-asserted-by":"publisher","first-page":"986","DOI":"10.47391\/JPMA.22-63","volume":"72","author":"VK Ramdas Nayak","year":"2022","unstructured":"Ramdas Nayak VK, Satheesh P, Shenoy MT, et al. Triglyceride glucose (TyG) index: A surrogate biomarker of insulin resistance. J Pak Med Assoc. 2022;72(5):986\u20138.","journal-title":"J Pak Med Assoc"},{"issue":"1","key":"2188_CR8","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1186\/s12933-023-02115-9","volume":"23","author":"K Dang","year":"2024","unstructured":"Dang K, Wang X, Hu J, et al. The association between triglyceride-glucose index and its combination with obesity indicators and cardiovascular disease: NHANES 2003\u20132018. Cardiovasc Diabetol. 2024;23(1):8.","journal-title":"Cardiovasc Diabetol"},{"key":"2188_CR9","doi-asserted-by":"publisher","first-page":"m997","DOI":"10.1136\/bmj.m997","volume":"369","author":"Y Li","year":"2020","unstructured":"Li Y, Teng D, Shi X, et al. Prevalence of diabetes recorded in Mainland China using 2018 diagnostic criteria from the American diabetes association: National cross sectional study. BMJ. 2020;369:m997.","journal-title":"BMJ"},{"issue":"6","key":"2188_CR10","first-page":"461","volume":"43","author":"Chinese Multidisciplinary Expert Consensus Group on the Diagnosis and Treatment of Diseases Related to Hyperuricemia, Branch of Critical Metabolic Diseases, Chinese National Health Association","year":"2023","unstructured":"Chinese Multidisciplinary Expert Consensus Group on the Diagnosis and Treatment of Diseases Related to Hyperuricemia, Branch of Critical Metabolic Diseases, Chinese National Health Association. Chinese multidisciplinary expert consensus on the diagnosis and treatment of diseases related to hyperuricemia (2023 Edition) [J]. Chin J Practical Intern Med. 2023;43(6):461\u201380.","journal-title":"Chin J Practical Intern Med"},{"issue":"36","key":"2188_CR11","doi-asserted-by":"publisher","first-page":"5856","DOI":"10.2174\/0929867331666230809143758","volume":"31","author":"ID Karantas","year":"2024","unstructured":"Karantas ID, Miliotou AN, Siafaka PI. An updated review for hyperuricemia and gout Management; special focus on the available drug delivery systems and clinical trials. Curr Med Chem. 2024;31(36):5856\u201383.","journal-title":"Curr Med Chem"},{"issue":"10","key":"2188_CR12","doi-asserted-by":"publisher","first-page":"2557","DOI":"10.1002\/art.39254","volume":"67","author":"T Neogi","year":"2015","unstructured":"Neogi T, Jansen TL, Dalbeth N, et al. 2015 gout classification criteria: an American college of Rheumatology\/European league against rheumatism collaborative initiative. Arthritis Rheumatol. 2015;67(10):2557\u201368.","journal-title":"Arthritis Rheumatol"},{"key":"2188_CR13","doi-asserted-by":"publisher","first-page":"6417205","DOI":"10.1155\/2024\/6417205","volume":"2024","author":"X Feng","year":"2024","unstructured":"Feng X, Deng Y, Chen C, et al. Predictive value of Triglyceride-Glucose index for All-Cause and cardiovascular mortality in patients with diabetes mellitus: A retrospective study: TyG index and mortality in diabetes. Int J Endocrinol. 2024;2024:6417205.","journal-title":"Int J Endocrinol"},{"issue":"1","key":"2188_CR14","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1093\/ije\/dyz078","volume":"49","author":"R Ng","year":"2020","unstructured":"Ng R, Sutradhar R, Yao Z, et al. Smoking, drinking, diet and physical activity-modifiable lifestyle risk factors and their associations with age to first chronic disease. Int J Epidemiol. 2020;49(1):113\u201330.","journal-title":"Int J Epidemiol"},{"issue":"11","key":"2188_CR15","doi-asserted-by":"publisher","first-page":"3390","DOI":"10.1111\/dom.15238","volume":"25","author":"K Chen","year":"2023","unstructured":"Chen K, Shen Z, Gu W, et al. Prevalence of obesity and associated complications in china: A cross-sectional, real-world study in 15.8 million adults. Diabetes Obes Metab. 2023;25(11):3390\u20139.","journal-title":"Diabetes Obes Metab"},{"key":"2188_CR16","doi-asserted-by":"crossref","unstructured":"Kutoh E, Wada A, Murayama T, et al. Characterization of metabolic parameters in responders and nonresponders treated with canagliflozin monotherapy in drug-naive subjects with type 2 diabetes. Indian J Endocrinol Metab. 2018 Mar-Apr;22(2):185\u201390.","DOI":"10.4103\/ijem.IJEM_578_17"},{"key":"2188_CR17","doi-asserted-by":"publisher","first-page":"92","DOI":"10.1186\/s13098-020-00600-9","volume":"12","author":"T Yuan","year":"2020","unstructured":"Yuan T, Liu S, Dong Y, et al. Effects of Dapagliflozin on serum and urinary uric acid levels in patients with type 2 diabetes: a prospective pilot trial. Diabetol Metab Syndr. 2020;12:92.","journal-title":"Diabetol Metab Syndr"},{"issue":"11","key":"2188_CR18","doi-asserted-by":"publisher","first-page":"e090415","DOI":"10.1136\/bmjopen-2024-090415","volume":"14","author":"S Stewart","year":"2024","unstructured":"Stewart S, Gamble G, Taylor W, et al. Development of gout in people with asymptomatic hyperuricemia: study protocol for a 5-year prospective cohort. BMJ Open. 2024;14(11):e090415.","journal-title":"BMJ Open"},{"issue":"6","key":"2188_CR19","doi-asserted-by":"publisher","first-page":"1281","DOI":"10.3904\/kjim.2020.340","volume":"36","author":"Y Waheed","year":"2021","unstructured":"Waheed Y, Yang F, Sun D. Role of asymptomatic hyperuricemia in the progression of chronic kidney disease and cardiovascular disease. Korean J Intern Med. 2021;36(6):1281\u201393.","journal-title":"Korean J Intern Med"},{"issue":"11","key":"2188_CR20","doi-asserted-by":"publisher","first-page":"3075","DOI":"10.1007\/s10067-023-06710-9","volume":"42","author":"H Hashimoto","year":"2023","unstructured":"Hashimoto H, Takeuchi M, Kawakami K. Association between urate-lowering therapy and cardiovascular events in patients with asymptomatic hyperuricemia. Clin Rheumatol. 2023;42(11):3075\u201382.","journal-title":"Clin Rheumatol"},{"issue":"8","key":"2188_CR21","doi-asserted-by":"publisher","first-page":"1390","DOI":"10.1097\/HJH.0000000000003744","volume":"42","author":"J Che","year":"2024","unstructured":"Che J, Tong J, Kuang X, et al. Hyperuricemia and gout enhanced the risk of long-term mortality in hypertension: insights from the National health and nutrition examination survey 2007\u20132018. J Hypertens. 2024;42(8):1390\u20138.","journal-title":"J Hypertens"},{"issue":"6","key":"2188_CR22","doi-asserted-by":"publisher","first-page":"2346","DOI":"10.1093\/rheumatology\/keab739","volume":"61","author":"S Kojima","year":"2022","unstructured":"Kojima S, Uchiyama K, Yokota N, et al. Optimal uric acid levels by febuxostat treatment and cerebral, cardiorenovascular risks: post hoc analysis of a randomized controlled trial. Rheumatology (Oxford). 2022;61(6):2346\u201359.","journal-title":"Rheumatology (Oxford)"},{"issue":"12","key":"2188_CR23","doi-asserted-by":"publisher","first-page":"2227","DOI":"10.1007\/s11255-019-02256-5","volume":"51","author":"C Hu","year":"2019","unstructured":"Hu C, Wu X. Treatment of asymptomatic hyperuricemia complicated by renal damage: a controversial issue. Int Urol Nephrol. 2019;51(12):2227\u201333.","journal-title":"Int Urol Nephrol"},{"issue":"3","key":"2188_CR24","doi-asserted-by":"publisher","first-page":"105679","DOI":"10.1016\/j.jbspin.2023.105679","volume":"91","author":"J Zhao","year":"2024","unstructured":"Zhao J, Sha B, Zeng L, et al. J-shaped association of serum uric acid concentrations with all-cause mortality in individuals with osteoarthritis: A prospective cohort study. Joint Bone Spine. 2024;91(3):105679.","journal-title":"Joint Bone Spine"},{"issue":"12","key":"2188_CR25","doi-asserted-by":"publisher","first-page":"3169","DOI":"10.3390\/biomedicines11123169","volume":"11","author":"A Nakayama","year":"2023","unstructured":"Nakayama A, Kurajoh M, Toyoda Y, et al. Dysuricemia Biomedicines. 2023;11(12):3169.","journal-title":"Dysuricemia Biomedicines"},{"key":"2188_CR26","doi-asserted-by":"publisher","first-page":"1403858","DOI":"10.3389\/fendo.2024.1403858","volume":"15","author":"R Gou","year":"2024","unstructured":"Gou R, Dou D, Tian M, et al. Association between triglyceride glucose index and hyperuricemia: a new evidence from China and the united States. Front Endocrinol (Lausanne). 2024;15:1403858.","journal-title":"Front Endocrinol (Lausanne)"},{"issue":"14","key":"2188_CR27","doi-asserted-by":"publisher","first-page":"3139","DOI":"10.3390\/nu15143139","volume":"15","author":"Y Han","year":"2023","unstructured":"Han Y, Zhou Z, Zhang Y, et al. The association of surrogates of insulin resistance with hyperuricemia among Middle-Aged and older individuals: A Population-Based nationwide cohort study. Nutrients. 2023;15(14):3139.","journal-title":"Nutrients"},{"issue":"1","key":"2188_CR28","doi-asserted-by":"publisher","first-page":"e23","DOI":"10.1016\/S2666-7568(22)00247-1","volume":"4","author":"P Lopez-Jaramillo","year":"2023","unstructured":"Lopez-Jaramillo P, Gomez-Arbelaez D, Martinez-Bello D, et al. Association of the triglyceride glucose index as a measure of insulin resistance with mortality and cardiovascular disease in populations from five continents (PURE study): a prospective cohort study. Lancet Healthy Longev. 2023;4(1):e23\u201333.","journal-title":"Lancet Healthy Longev"},{"issue":"1","key":"2188_CR29","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1186\/s12902-024-01542-3","volume":"24","author":"S Lertsakulbunlue","year":"2024","unstructured":"Lertsakulbunlue S, Sangkool T, Bhuriveth V, et al. Associations of triglyceride-glucose index with hyperuricemia among Royal Thai army personnel. BMC Endocr Disord. 2024;24(1):17.","journal-title":"BMC Endocr Disord"},{"key":"2188_CR30","doi-asserted-by":"publisher","first-page":"2407","DOI":"10.2147\/TCRM.S186347","volume":"14","author":"Z Hao","year":"2018","unstructured":"Hao Z, Huang X, Shao H, et al. Effects of Dapagliflozin on serum uric acid levels in hospitalized type 2 diabetic patients with inadequate glycemic control: a randomized controlled trial. Ther Clin Risk Manag. 2018;14:2407\u201313.","journal-title":"Ther Clin Risk Manag"},{"issue":"7","key":"2188_CR31","first-page":"268","volume":"10","author":"A Kochanowska","year":"2023","unstructured":"Kochanowska A, Rusztyn P, Szczerkowska K, et al. Sodium-Glucose cotransporter 2 inhibitors to decrease the uric acid Concentration-A novel mechanism of action. J Cardiovasc Dev Dis. 2023;10(7):268.","journal-title":"J Cardiovasc Dev Dis"},{"issue":"1","key":"2188_CR32","doi-asserted-by":"publisher","first-page":"4849","DOI":"10.1038\/s41598-023-32072-y","volume":"13","author":"Y Iwata","year":"2023","unstructured":"Iwata Y, Notsu S, Kawamura Y, et al. The effect of Dapagliflozin on uric acid excretion and serum uric acid level in advanced CKD. Sci Rep. 2023;13(1):4849.","journal-title":"Sci Rep"},{"issue":"11","key":"2188_CR33","doi-asserted-by":"publisher","first-page":"534","DOI":"10.5414\/CP204606","volume":"62","author":"S Park","year":"2024","unstructured":"Park S, Chi S, Yang JH, et al. Comparison of uric acid elevation between aspirin-ticagrelor and aspirin-clopidogrel during dual antiplatelet therapy. Int J Clin Pharmacol Ther. 2024;62(11):534\u20137.","journal-title":"Int J Clin Pharmacol Ther"},{"issue":"13","key":"2188_CR34","doi-asserted-by":"publisher","first-page":"1726","DOI":"10.2174\/0929867330666230207124516","volume":"31","author":"A Akbari","year":"2024","unstructured":"Akbari A, Razmi M, Rafiee M, et al. The effect of Statin therapy on serum uric acid levels: A systematic review and Meta-analysis. Curr Med Chem. 2024;31(13):1726\u201339.","journal-title":"Curr Med Chem"},{"issue":"6","key":"2188_CR35","doi-asserted-by":"publisher","first-page":"305","DOI":"10.1097\/MBP.0000000000000725","volume":"29","author":"T Horio","year":"2024","unstructured":"Horio T, Iwashima Y, Yoshiyama M, et al. Serum uric acid-lowering effect of sacubitril\/valsartan in hypertensive patients: evaluation by switching from angiotensin II receptor blockers. Blood Press Monit. 2024;29(6):305\u201311.","journal-title":"Blood Press Monit"}],"container-title":["BMC Endocrine Disorders"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12902-026-02188-z","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12902-026-02188-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12902-026-02188-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,2,19]],"date-time":"2026-02-19T14:00:07Z","timestamp":1771509607000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s12902-026-02188-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,2,7]]},"references-count":35,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["2188"],"URL":"https:\/\/doi.org\/10.1186\/s12902-026-02188-z","relation":{},"ISSN":["1472-6823"],"issn-type":[{"value":"1472-6823","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,2,7]]},"assertion":[{"value":"17 April 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 February 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 February 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Our clinical research protocol was approved by the Ethics Committee of Tianjin Fourth Central Hospital (IRB No. 2017-SZXLL020). Patients were apprised regarding this study and provided written informed consent. This study was registered in the Chinese Clinical Trial Registry (ChiCTR1800015830, registration date: 2018\/04\/23), and adhered to the principles of the Declaration of Helsinki.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"65"}}